At Fortrea, we have some amazing data sources, and we also have relationships with data providers where we’re bringing in different diversity data and site line data into our database. Watch the complete video: https://lnkd.in/eJQTRC34
About us
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development and patient access solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients in need. Fortrea provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology-enabled trial solutions and post-approval services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team of approximately 19,000 people working in more than 90 countries is scaled to deliver focused and agile solutions to customers globally. Learn more about how Fortrea is becoming a transformative force from pipeline to patient at Fortrea.com.
- Website
-
https://fortrea.com
External link for Fortrea
- Industry
- Hospitals and Health Care
- Company size
- 10,001+ employees
- Headquarters
- Research Triangle Park, NC
- Type
- Public Company
Locations
-
Primary
Research Triangle Park, NC, US
Employees at Fortrea
-
Alan Switzer
Clinical systems and process specialist | Digital transformation expert | Collaborative partner | Client Engagement Leader at Fortrea.
-
Linda Watkins
I have finally found my professional home!
-
Miroslaw (Mirek) Dudek
Associate Director, Change Management at Fortrea
-
Robert Boman
Global Creative Director | Team Builder | Omni-channel Storyteller | BBQ Snob
Updates
-
Tired of clinical trials stalling due to insufficient patient enrollment? We helped a global diagnostics company overcome this challenge and complete their pivotal trial 30 days early. Want to know how? Check out our latest blog post to learn more about the strategies we employed to successfully recruit over 5,000 patients in a timely manner. https://lnkd.in/eHjizjYn #clinicaltrials #patientenrollment #fortrea #biotech #pharma
-
Fortrea’s extensive global network of reliable sites is uniquely positioned to predict the number, location, and specific sites needed to achieve your clinical trial’s recruitment and retention goals. Our collaborative approach involves actively seeking input from partner sites on protocol design, ensuring that protocols are feasible and appealing to patients. Learn more at https://lnkd.in/e6uF8Zuj
This content isn’t available here
Access this content and more in the LinkedIn app
-
Fortrea has a patient recruitment and engagement team that works really closely with our sites and our sponsors to understand the journey of the patient to the clinic. https://lnkd.in/emhcnJ2i Want to learn more about Fortrea Site Connections? https://lnkd.in/e6uF8Zuj
-
Gabriel joined Fortrea in pursuit of professional growth. With his diverse skill set and exceptional proficiency in the Swedish language, he quickly found a home in Fortrea's global community. In a short span, Gabriel has already expanded his role, taking on additional responsibilities in quality assurance and patient safety, with the support of his training and collaborative colleagues. Gabriel's story is an inspiration to those seeking dynamic career growth and patient care. If you are looking for an opportunity to make a difference in the healthcare field, then Fortrea is the place for you. Discover exciting openings with Fortrea at https://lnkd.in/gfaSPcKy #ForwardwithFortrea #TeamFortrea
-
We snapped a few pix of Fortrea's respiratory experts at the 8th Annual IPF Summit in Boston! Veerle Van De Velde spoke today at the industry’s largest drug development initiative for the pulmonary fibrosis community. Mark Dowling, Joan Folbrecht, PMP and Yeonjoo Chloe Kang rounded out the Fortrea team. https://lnkd.in/emDTQTjj #IPF #pulmonaryfibrosis #fibroticlungdisease #respiratorymedicine
-
We want sites to get back to doing what they do best. Not dealing with technology, or difficulty and workflow from complex protocols, but actually providing patient care. That’s what they do best. https://lnkd.in/emhcnJ2i Want to learn more about Fortrea Site Connections? https://lnkd.in/e6uF8Zuj #clinicaltrials #patientcare
-
🌍 Will you be at ISPE 2024 in Berlin? At Fortrea, we're leveraging real-world data and external control arms to deliver comprehensive real-world evidence solutions that meet clients’ needs throughout the drug development process. We look forward to connecting with you at #ISPE2024 as we explore how we can help you drive innovation and improve outcomes! Stop by our poster presentation on August 27th, titled “Improving the Role of External Control Arms in Early-Phase Single Arm Trials.” 📍 Poster Number: 189 🗓️ Session: Poster Session B, August 27th 🏛️ Room: Convention Hall II https://lnkd.in/eCzJ4smu #Fortrea #RealWorldEvidence #ExternalControlArms #HealthcareInnovation
-
Exciting news for European SMEs developing next-generation treatments! The European Commission is backing innovation with regulations specifically designed to support your development of Combined Advanced Therapy Medicinal Products (CATMPs). The EMA ATMP classification procedure can maximize your chance of success in obtaining marketing authorization. Want to learn more? ➡️ Our blog has a FREE white paper that delves deeper into the challenges, opportunities, and how to leverage these regulations: https://lnkd.in/e6w4axuN #CATMP #HealthcareInnovation #EUFunding #SMEOpportunities
-
As a nephrologist, Dr. Barbara Gillespie has been deeply involved in legislation to transform kidney care in the United States. Read her latest: https://lnkd.in/gbh2mFF4
Check out my recent op-ed for @RealClearHealth where I call on Congress to support the New Era of Preventing End-Stage Kidney Disease Act (H.R. 6790). This bipartisan legislation could truly transform kidney care, promoting early diagnosis, equitable care, and the advancement of research in our field. I invite you to read my full article and join @NephCure in advocating for the #NewEraAct. Together, we can make a real difference in the lives of millions of Americans impacted by kidney disease and their families: https://lnkd.in/eUGC-TZi